MetaCap

iRadimed Corporation (IRMD)

NASDAQ: IRMDHealth CareMedical/Dental InstrumentsUSD

81.02-0.24 (-0.30%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IRMD stock chart

Technical analysis

Key statistics

All statistics
Dividend yield
0.99% ($0.80)
Ex-dividend date
Nov 13, 2026
52-week range
76.35 – 107.90
Day range
80.61 – 82.11
Volume / Avg
101.30K / 120.89K
Beta
—

52-week range

$76.35$107.90

IRMD stock today

iRadimed (IRMD) closed at $81.02 on Nov 20, down 0.30% (-$0.24), versus the S&P 500's 3.70% decline. At this level, IRMD sits near the bottom of its 52-week range of $76.35 to $107.90: 24.9% below the high, set on Feb 10, 2026 and 6.1% above the low. IRMD is down 16.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 9.5%.

iRadimed trades at 43.3x its trailing twelve-month earnings per share of $1.87. Its forward P/E of 33.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. iRadimed pays an annual dividend of $0.80 per share, a 0.99% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About iRadimed

Company profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.

Industry
Medical/Dental Instruments
CEO
Mr. Roger E. Susi
Headquarters
Orlando, FL
Employees
166
IPO year
2014

Financial highlights

Full financials

In fiscal 2025, iRadimed generated $83.8 million in revenue, up 14.4% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $22.5 million (+16.9% year over year), for a net margin of 26.8% versus a median of 24.1% in the prior 5 years. Gross margin was 76.7% (down from 76.9%) and operating margin 31.2%.

iRadimed annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$83.81M$73.24M$65.56M$53.30M$41.81M
Growth+14.43%+11.71%+23.00%+27.48%+31.83%
Net income$22.48M$19.23M$17.19M$12.83M$9.33M
EPS (diluted)$1.75$1.50$1.35$1.02$0.74

Analyst forecast

Forecast

Consensus (3 analysts)

none

Avg. price target

$118.00+45.64%

  • Strong buy 0
  • Buy 2
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $116.00High $120.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 30, 2026
EPS actual vs est.
$0.51 vs $0.52
Surprise
-1.92%

Dividends

Dividend history
Annual dividend
$0.80
Last payment
$0.20
Ex-dividend date
Nov 13, 2026
Pay date
Nov 27, 2026

IRMD news

All IRMD news

iRadimed peers

Health Care sector
IRMD peer companies
CompanyPrice% ChgMarket capCompare
IARTIntegra LifeSciences Holdings Corporation13.25-2.21%$1.03Bvs IRMD
ATECAlphatec Holdings Inc.6.68-3.19%$1.02Bvs IRMD
SGPSpyGlass Pharma Inc.30.43-1.14%$1.02Bvs IRMD
SIBNSI-BONE Inc.23.73-0.08%$1.07Bvs IRMD
DRTSAlpha Tau Medical Ltd.11.76+3.93%$1.09Bvs IRMD
AORTArtivion Inc.18.16-2.00%$886.02Mvs IRMD
TNDMTandem Diabetes Care Inc.17.46+3.93%$1.22Bvs IRMD
KIDSOrthoPediatrics Corp.31.74-2.37%$828.75Mvs IRMD

Indexes, lists and sector

iRadimed stock FAQ

What is iRadimed's stock price today?

IRMD last traded at $81.02 as of Nov 20, 4:00 PM EST, down 0.30% on the day. Prices are delayed at least 15 minutes.

Does iRadimed pay a dividend?

Yes. iRadimed pays $0.80 per share annually, a 0.99% yield. The most recent dividend of $0.20 had an ex-dividend date of Nov 13, 2026.

What is IRMD's P/E ratio?

IRMD trades at a trailing P/E ratio of 43.33 and a forward P/E of 33.25.

Who is iRadimed's CEO?

Mr. Roger E. Susi is the chief executive officer of iRadimed Corporation, which has about 166 employees.

What is the IRMD 52-week high?

The 52-week high for IRMD is $107.90 and the 52-week low is $76.35. The stock is currently 24.9% below its high.

Compare IRMD